|
Tissera
is dedicated to the advancement of a new era
in tissue
transplantation with precursor transplant technology.
Progress in
transplantation technologies has improved and lengthened the lives of tens of thousands of
people.
However,
the shortage of donor tissue forces patients to wait years for a
suitable organ. In addition, the heavy immune suppression needed to
ascertain engraftment is associated with long term complications.
Tissera
seeks
to surmount these obstacles and provide tissue transplant solutions for
many health problems not effectively treated today.
The
Tissera
technology developed at the
Weizman Institute of Science is described in a landmark study
published in Nature Medicine magazine. It provides hope for effectively
treating gene deficiencies and a great variety of diseases.
Tissera's
transplant technology minimizes the need for immunosuppressive drugs.
Tissera's
future tissue products will potentially be available on demand -
eliminating the need to wait years for organ transplantation. |
